In the News
Genome Web: DuPont, Caribou Biosciences Ink Strategic Alliance on CRISPR, Cross-License IP
DuPont and Caribou Biosciences today announced a strategic alliance focused on agricultural applications of CRISPR/Cas9 genome editing.
Xconomy: West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More
We were stuck for a couple days in a Nobel vortex. Speculation about a Nobel Prize in chemistry for University of California, Berkeley scientist Jennifer Doudna and her gene-editing research partner, Emmanuelle Charpentier, swirled and swirled until everyone following it got a bit dizzy.
Berkeley News: Doudna receives Women in Science Award from L’Oreal-UNESCO
UC Berkeley professor Jennifer Doudna, who invented a gene-editing tool that has taken the research world by storm, was named one of five laureates of the 2016 L’Oréal-UNESCO for Women in Science Awards in the field of life sciences.
Chemical & Engineering News: The 2015 Top 20 Drugs in the Pipeline
While anticipation mounts that the FDA may rubber stamp a gene therapy technique for the first time within the next couple of years, excitement about a new, simple and highly-precise gene editing technique is reaching fever pitch.
Chemical & Engineering News: Genome Editing Writ Large
Information pouring in from accurate, low-cost gene-sequencing machines is allowing scientists to pose more and better genomic questions. But in the absence of easy-to-use genome-editing tools to experiment with, answers have been hard to come by. Starting to bridge this gap is a three-year-old editing approach called CRISPR/Cas9.